Syngen Biotech Market Cap

Syngen Biotech has a market cap or net worth of 3.60 billion as of June 13, 2025. Its market cap has decreased by -11.92% in one year.

Market Cap

3.60B

Enterprise Value

3.63B

Revenue

2.03B

Ranking

n/a

PE Ratio

14.94

Stock Price

133.00

Market Cap Chart

Since November 2, 2004, Syngen Biotech's market cap has increased from 372.00M to 3.60B, an increase of 868.93%. That is a compound annual growth rate of 11.64%.

Market Cap History

Date	Market Cap	% Change
Jun 13, 2025	3.60B	4.72%
Dec 30, 2024	3.44B	-16.45%
Dec 29, 2023	4.12B	-6.17%
Dec 30, 2022	4.39B	43.36%
Dec 30, 2021	3.06B	4.63%
Dec 31, 2020	2.93B	-8.09%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	180.96B
Caliway Biopharmaceuticals	149.82B
Bora Pharmaceuticals Co., LTD.	83.79B
Lotus Pharmaceutical	60.82B
Polaris Group	30.66B
Center Laboratories	29.36B
Lumosa Therapeutics	28.02B
Oneness Biotech	27.36B

Market Cap Rankings